YMRC
CMD

Yorktown Management & Research Company’s Cantel Medical Corporation CMD Stock Holding History

Yorktown Management & Research Company’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,204
Closed -$482K – 362
2019
Q1 		$482K Buy
7,204
+500
+7% +$37.9K 0.16% 161
2018
Q4 		$499K Sell
6,704
-2,702
-29% -$223K 0.17% 147
2018
Q3 		$866K Buy
9,406
+558
+6% +$53.1K 0.25% 111
2018
Q2 		$870K Buy
8,848
+748
+9% +$83.7K 0.25% 112
2018
Q1 		$902K Hold
8,100
– – 0.27% 101
2017
Q4 		$833K Buy
8,100
+3,100
+62% +$309K 0.24% 106
2017
Q3 		$471K Buy
+5,000
New +$395K 0.12% 116

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Yorktown Management & Research Company's CMD Position: Q2 2019 in Review

Yorktown Management & Research Company sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 7,204 shares — an estimated $482K sold.

Yorktown Management & Research Company first reported a position in CMD in Q3 2017 and held it in 7 quarters. The position peaked at $902K in Q1 2018. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Yorktown Management & Research Company reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Yorktown Management & Research Company sold 7,204 Cantel Medical Corporation shares in Q2 2019, an estimated $482K.
  • Yorktown Management & Research Company first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 7 quarters.
  • Yorktown Management & Research Company's Cantel Medical Corporation position peaked at $902K in Q1 2018.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Yorktown Management & Research Company's 13F filing for Q2 2019, filed 2 Aug 2019.